Lilly Asia Ventures
Lilly Asia Ventures
VC investments in life sciences
Investment Fund Manager | China | Health Improvement
Overview
Lilly Asia Ventures (LAV) is a healthcare focused venture capital and private equity firm based in Shanghai and Hong Kong. LAV's investment strategy is industry specific but stage agnostic. Major coverage areas include biopharmaceuticals medical devices diagnostics healthcare services and health IT.
Investor Type |
Legal Structure |
Operating Status |
Members |
| Investment Fund Manager | Other Legal Structure | Operating | 11-50 |
Portfolio
Jun, 2016
Joint Series A Equity PRI
Just Biotherapeutics
Focused on the technology of biotherapeutics
Just is an integrated design company focused on the technology...
sector
Health Improvement
Disease Specific Prevention and Mitigation
Capacity Building
regions
United States of America
People
Investors / Funders
Team
Funds
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Headquarters :
Room 2909 3 Corporate Avenue
No.168 Hubin Road
Shanghai
China